Leader
|
|
|
00000nz a2200037n 45 0 |
001
|
|
|
WKP|Q57006508
(VIAF cluster)
(Authority/Source Record)
|
003
|
|
|
WKP |
005
|
|
|
20241221010844.0 |
008
|
|
|
241221nneanz||abbn n and d |
035
|
|
|
‡a
(WKP)Q57006508
|
024
|
|
|
‡a
0000-0001-9634-4323
‡2
orcid
|
035
|
|
|
‡a
(OCoLC)Q57006508
|
100
|
0 |
|
‡a
Laurent Muller
‡c
researcher (ORCID 0000-0001-9634-4323)
‡9
en
|
375
|
|
|
‡a
1
‡2
iso5218
|
400
|
0 |
|
‡a
Laurent Muller
‡c
onderzoeker
‡9
nl
|
670
|
|
|
‡a
Author's A 36-residue peptide contains all of the information required for 7B2-mediated activation of prohormone convertase 2.
|
670
|
|
|
‡a
Author's Akt down-regulates ERK1/2 nuclear localization and angiotensin II-induced cell proliferation through PEA-15.
|
670
|
|
|
‡a
Author's Cloning and functional analysis of C. elegans 7B2.
|
670
|
|
|
‡a
Author's Corrigendum: How Tissue Mechanical Properties Affect Enteric Neural Crest Cell Migration
|
670
|
|
|
‡a
Author's Coupling between Myogenesis and Angiogenesis during Skeletal Muscle Regeneration Is Stimulated by Restorative Macrophages.
|
670
|
|
|
‡a
Author's Extracellular matrix-bound angiopoietin-like 4 inhibits endothelial cell adhesion, migration, and sprouting and alters actin cytoskeleton
|
670
|
|
|
‡a
Author's Extracellular matrix scaffolding in angiogenesis and capillary homeostasis
|
670
|
|
|
‡a
Author's Glucagon-like Peptide 1 Receptor Agonists, Diabetic Retinopathy and Angiogenesis: The AngioSafe Type 2 Diabetes Study
|
670
|
|
|
‡a
Author's Heterodimerization of endothelin-converting enzyme-1 isoforms regulates the subcellular distribution of this metalloprotease
|
670
|
|
|
‡a
Author's Hypoxia-driven angiogenesis: role of tip cells and extracellular matrix scaffolding.
|
670
|
|
|
‡a
Author's Identification of multiple subunits of heterotrimeric G proteins on the membrane of secretory granules in rat prolactin anterior pituitary cells
|
670
|
|
|
‡a
Author's Immunocytochemical localization of the prohormone convertases PC1 and PC2 in rat prolactin cells
|
670
|
|
|
‡a
Author's Increased VEGFR2 expression during human late endothelial progenitor cells expansion enhances in vitro angiogenesis with up-regulation of integrin alpha(6)
|
670
|
|
|
‡a
Author's Initial clonogenic potential of human endothelial progenitor cells is predictive of their further properties and establishes a functional hierarchy related to immaturity.
|
670
|
|
|
‡a
Author's Interaction of the coiled-coil domain with glycosaminoglycans protects angiopoietin-like 4 from proteolysis and regulates its antiangiogenic activity.
|
670
|
|
|
‡a
Author's Loss-of-function point mutations associated with renal tubular dysgenesis provide insights about renin function and cellular trafficking
|
670
|
|
|
‡a
Author's LOXL4 is induced by transforming growth factor β1 through Smad and JunB/Fra2 and contributes to vascular matrix remodeling.
|
670
|
|
|
‡a
Author's Lysyl oxidase-like 2 (LOXL2)-mediated cross-linking of tropoelastin
|
670
|
|
|
‡a
Author's Lysyl oxidase-like protein-2 regulates sprouting angiogenesis and type IV collagen assembly in the endothelial basement membrane
|
670
|
|
|
‡a
Author's Mechanism of the Facilitation of PC2 Maturation by 7B2: Involvement in ProPC2 Transport and Activation but Not Folding
|
670
|
|
|
‡a
Author's Mutations in the catalytic domain of prohormone convertase 2 result in decreased binding to 7B2 and loss of inhibition with 7B2 C-terminal peptide.
|
670
|
|
|
‡a
Author's PAR-1 activation on human late endothelial progenitor cells enhances angiogenesis in vitro with upregulation of the SDF-1/CXCR4 system.
|
670
|
|
|
‡a
Author's Priming Dental Pulp Stem Cells With Fibroblast Growth Factor-2 Increases Angiogenesis of Implanted Tissue-Engineered Constructs Through Hepatocyte Growth Factor and Vascular Endothelial Growth Factor Secretion
|
670
|
|
|
‡a
Author's Processing and sorting of the prohormone convertase 2 propeptide
|
670
|
|
|
‡a
Author's Production and secretion of N-terminal secretogranin II derived peptides in GH3B6 prolactin cells
|
670
|
|
|
‡a
Author's Scavenger Receptor Cysteine-Rich domains of Lysyl Oxidase-Like2 regulate endothelial ECM and angiogenesis through non-catalytic scaffolding mechanisms
|
670
|
|
|
‡a
Author's Small interfering RNA molecules targeting endothelin-converting enzyme-1 inhibit endothelin-1 synthesis and the invasive phenotype of ovarian carcinoma cells.
|
670
|
|
|
‡a
Author's Structural elements of PC2 required for interaction with its helper protein 7B2.
|
670
|
|
|
‡a
Author's The C-terminal domain of aminopeptidase A is an intramolecular chaperone required for the correct folding, cell surface expression, and activity of this monozinc aminopeptidase.
|
670
|
|
|
‡a
Author's The interaction of heparan sulfate proteoglycans with endothelial transglutaminase-2 limits VEGF165-induced angiogenesis
|
670
|
|
|
‡a
Author's The Interactome of Cancer-Related Lysyl Oxidase and Lysyl Oxidase-Like Proteins
|
670
|
|
|
‡a
wikidata authority control
‡u
https://viaf.org/viaf/39146573871538101181
|
670
|
|
|
‡a
wikidata authority control
‡u
https://viaf.org/processed/SUDOC|19307625X
|
909
|
|
|
‡a
(orcid) 0000000196344323
‡9
1
|
919
|
|
|
‡a
100terminaldomainofaminopeptidaseaisanintramolecularchaperonerequiredforthecorrectfoldingcellsurfaceexpressionandactivityofthismonozincaminopeptidase
‡A
The C-terminal domain of aminopeptidase A is an intramolecular chaperone required for the correct folding, cell surface expression, and activity of this monozinc aminopeptidase.
‡9
1
|
919
|
|
|
‡a
interactionofheparansulfateproteoglycanswithendothelialtransglutaminase2limitsvegf165inducedangiogenesis
‡A
The interaction of heparan sulfate proteoglycans with endothelial transglutaminase-2 limits VEGF165-induced angiogenesis
‡9
1
|
919
|
|
|
‡a
36residuepeptidecontainsalloftheinformationrequiredfor7b2mediatedactivationofprohormoneconvertase2
‡A
A 36-residue peptide contains all of the information required for 7B2-mediated activation of prohormone convertase 2.
‡9
1
|
919
|
|
|
‡a
aktdownregulateserk12nuclearlocalizationandangiotensin2inducedcellproliferationthroughpea15
‡A
Akt down-regulates ERK1/2 nuclear localization and angiotensin II-induced cell proliferation through PEA-15.
‡9
1
|
919
|
|
|
‡a
interactomeofcancerrelatedlysyloxidaseandlysyloxidaselikeproteins
‡A
The Interactome of Cancer-Related Lysyl Oxidase and Lysyl Oxidase-Like Proteins
‡9
1
|
919
|
|
|
‡a
cloningandfunctionalanalysisof100elegans7b2
‡A
Cloning and functional analysis of C. elegans 7B2.
‡9
1
|
919
|
|
|
‡a
corrigendumhowtissuemechanicalpropertiesaffectentericneuralcrestcellmigration
‡A
Corrigendum: How Tissue Mechanical Properties Affect Enteric Neural Crest Cell Migration
‡9
1
|
919
|
|
|
‡a
couplingbetweenmyogenesisandangiogenesisduringskeletalmuscleregenerationisstimulatedbyrestorativemacrophages
‡A
Coupling between Myogenesis and Angiogenesis during Skeletal Muscle Regeneration Is Stimulated by Restorative Macrophages.
‡9
1
|
919
|
|
|
‡a
extracellularmatrixboundangiopoietinlike4inhibitsendothelialcelladhesionmigrationandsproutingandaltersactincytoskeleton
‡A
Extracellular matrix-bound angiopoietin-like 4 inhibits endothelial cell adhesion, migration, and sprouting and alters actin cytoskeleton
‡9
1
|
919
|
|
|
‡a
extracellularmatrixscaffoldinginangiogenesisandcapillaryhomeostasis
‡A
Extracellular matrix scaffolding in angiogenesis and capillary homeostasis
‡9
1
|
919
|
|
|
‡a
glucagonlikepeptide1receptoragonistsdiabeticretinopathyandangiogenesistheangiosafetype2diabetesstudy
‡A
Glucagon-like Peptide 1 Receptor Agonists, Diabetic Retinopathy and Angiogenesis: The AngioSafe Type 2 Diabetes Study
‡9
1
|
919
|
|
|
‡a
heterodimerizationofendothelinconvertingenzyme1isoformsregulatesthesubcellulardistributionofthismetalloprotease
‡A
Heterodimerization of endothelin-converting enzyme-1 isoforms regulates the subcellular distribution of this metalloprotease
‡9
1
|
919
|
|
|
‡a
hypoxiadrivenangiogenesisroleoftipcellsandextracellularmatrixscaffolding
‡A
Hypoxia-driven angiogenesis: role of tip cells and extracellular matrix scaffolding.
‡9
1
|
919
|
|
|
‡a
identificationofmultiplesubunitsofheterotrimericgproteinsonthemembraneofsecretorygranulesinratprolactinanteriorpituitarycells
‡A
Identification of multiple subunits of heterotrimeric G proteins on the membrane of secretory granules in rat prolactin anterior pituitary cells
‡9
1
|
919
|
|
|
‡a
immunocytochemicallocalizationoftheprohormoneconvertasespc1andpc2inratprolactincells
‡A
Immunocytochemical localization of the prohormone convertases PC1 and PC2 in rat prolactin cells
‡9
1
|
919
|
|
|
‡a
increasedvegfr2expressionduringhumanlateendothelialprogenitorcellsexpansionenhancesinvitroangiogenesiswithupregulationofintegrinalpha6
‡A
Increased VEGFR2 expression during human late endothelial progenitor cells expansion enhances in vitro angiogenesis with up-regulation of integrin alpha(6)
‡9
1
|
919
|
|
|
‡a
initialclonogenicpotentialofhumanendothelialprogenitorcellsispredictiveoftheirfurtherpropertiesandestablishesafunctionalhierarchyrelatedtoimmaturity
‡A
Initial clonogenic potential of human endothelial progenitor cells is predictive of their further properties and establishes a functional hierarchy related to immaturity.
‡9
1
|
919
|
|
|
‡a
interactionofthecoiledcoildomainwithglycosaminoglycansprotectsangiopoietinlike4fromproteolysisandregulatesitsantiangiogenicactivity
‡A
Interaction of the coiled-coil domain with glycosaminoglycans protects angiopoietin-like 4 from proteolysis and regulates its antiangiogenic activity.
‡9
1
|
919
|
|
|
‡a
lossoffunctionpointmutationsassociatedwithrenaltubulardysgenesisprovideinsightsaboutreninfunctionandcellulartrafficking
‡A
Loss-of-function point mutations associated with renal tubular dysgenesis provide insights about renin function and cellular trafficking
‡9
1
|
919
|
|
|
‡a
loxl4isinducedbytransforminggrowthfactorβ1throughsmadandjunbfra2andcontributestovascularmatrixremodeling
‡A
LOXL4 is induced by transforming growth factor β1 through Smad and JunB/Fra2 and contributes to vascular matrix remodeling.
‡9
1
|
919
|
|
|
‡a
lysyloxidaselike2loxl2mediatedcrosslinkingoftropoelastin
‡A
Lysyl oxidase-like 2 (LOXL2)-mediated cross-linking of tropoelastin
‡9
1
|
919
|
|
|
‡a
lysyloxidaselikeprotein2regulatessproutingangiogenesisandtype4collagenassemblyintheendothelialbasementmembrane
‡A
Lysyl oxidase-like protein-2 regulates sprouting angiogenesis and type IV collagen assembly in the endothelial basement membrane
‡9
1
|
919
|
|
|
‡a
mechanismofthefacilitationofpc2maturationby7b2involvementinpropc2transportandactivationbutnotfolding
‡A
Mechanism of the Facilitation of PC2 Maturation by 7B2: Involvement in ProPC2 Transport and Activation but Not Folding
‡9
1
|
919
|
|
|
‡a
mutationsinthecatalyticdomainofprohormoneconvertase2resultindecreasedbindingto7b2andlossofinhibitionwith7b2100terminalpeptide
‡A
Mutations in the catalytic domain of prohormone convertase 2 result in decreased binding to 7B2 and loss of inhibition with 7B2 C-terminal peptide.
‡9
1
|
919
|
|
|
‡a
par1activationonhumanlateendothelialprogenitorcellsenhancesangiogenesisinvitrowithupregulationofthesdf1cxcr4system
‡A
PAR-1 activation on human late endothelial progenitor cells enhances angiogenesis in vitro with upregulation of the SDF-1/CXCR4 system.
‡9
1
|
919
|
|
|
‡a
primingdentalpulpstemcellswithfibroblastgrowthfactor2increasesangiogenesisofimplantedtissueengineeredconstructsthroughhepatocytegrowthfactorandvascularendothelialgrowthfactorsecretion
‡A
Priming Dental Pulp Stem Cells With Fibroblast Growth Factor-2 Increases Angiogenesis of Implanted Tissue-Engineered Constructs Through Hepatocyte Growth Factor and Vascular Endothelial Growth Factor Secretion
‡9
1
|
919
|
|
|
‡a
processingandsortingoftheprohormoneconvertase2propeptide
‡A
Processing and sorting of the prohormone convertase 2 propeptide
‡9
1
|
919
|
|
|
‡a
productionandsecretionofnterminalsecretogranin2derivedpeptidesingh3b6prolactincells
‡A
Production and secretion of N-terminal secretogranin II derived peptides in GH3B6 prolactin cells
‡9
1
|
919
|
|
|
‡a
scavengerreceptorcysteinerichdomainsoflysyloxidaselike2regulateendothelialecmandangiogenesisthroughnoncatalyticscaffoldingmechanisms
‡A
Scavenger Receptor Cysteine-Rich domains of Lysyl Oxidase-Like2 regulate endothelial ECM and angiogenesis through non-catalytic scaffolding mechanisms
‡9
1
|
919
|
|
|
‡a
smallinterferingrnamoleculestargetingendothelinconvertingenzyme1inhibitendothelin1synthesisandtheinvasivephenotypeofovariancarcinomacells
‡A
Small interfering RNA molecules targeting endothelin-converting enzyme-1 inhibit endothelin-1 synthesis and the invasive phenotype of ovarian carcinoma cells.
‡9
1
|
919
|
|
|
‡a
structuralelementsofpc2requiredforinteractionwithitshelperprotein7b2
‡A
Structural elements of PC2 required for interaction with its helper protein 7B2.
‡9
1
|
946
|
|
|
‡a
b
‡9
1
|
996
|
|
|
‡2
DNB|134983785
|
996
|
|
|
‡2
CAOONL|ncf11502532
|
996
|
|
|
‡2
DNB|1012289990
|
996
|
|
|
‡2
DNB|1051499348
|
996
|
|
|
‡2
BIBSYS|1022720
|
996
|
|
|
‡2
BNL|9824030356907251
|
996
|
|
|
‡2
SELIBR|251804
|
996
|
|
|
‡2
DNB|1073497828
|
996
|
|
|
‡2
LC|n 2020031577
|
996
|
|
|
‡2
DNB|140260013
|
996
|
|
|
‡2
DNB|13185500X
|
996
|
|
|
‡2
DNB|143099981
|
996
|
|
|
‡2
DNB|1023633639
|
996
|
|
|
‡2
NTA|236461044
|
996
|
|
|
‡2
W2Z|14046175
|
996
|
|
|
‡2
RERO|A026881040
|
996
|
|
|
‡2
DNB|1064675476
|
996
|
|
|
‡2
DNB|132191865
|
996
|
|
|
‡2
DNB|121894908
|
996
|
|
|
‡2
SUDOC|086310836
|
996
|
|
|
‡2
SUDOC|175996865
|
996
|
|
|
‡2
DNB|103758445
|
996
|
|
|
‡2
ISNI|0000000393800092
|
996
|
|
|
‡2
BNF|13531568
|
996
|
|
|
‡2
NTA|158587170
|
996
|
|
|
‡2
CAOONL|ncf11004199
|
996
|
|
|
‡2
RERO|A003617942
|
996
|
|
|
‡2
DNB|129802069
|
996
|
|
|
‡2
DNB|1110072708
|
996
|
|
|
‡2
NTA|173803369
|
996
|
|
|
‡2
ISNI|000000039124028X
|
996
|
|
|
‡2
SZ|1196053472
|
996
|
|
|
‡2
RERO|A020120859
|
996
|
|
|
‡2
J9U|987007293036505171
|
996
|
|
|
‡2
SUDOC|252714539
|
996
|
|
|
‡2
DNB|129355240
|
996
|
|
|
‡2
DNB|1091067120
|
996
|
|
|
‡2
SUDOC|257713557
|
996
|
|
|
‡2
DNB|1047633507
|
996
|
|
|
‡2
DNB|104168412
|
996
|
|
|
‡2
RERO|A012336183
|
996
|
|
|
‡2
LC|nr 99033970
|
996
|
|
|
‡2
RERO|A014110598
|
996
|
|
|
‡2
CAOONL|ncf11907090
|
996
|
|
|
‡2
ISNI|000000011662780X
|
996
|
|
|
‡2
DNB|173390323
|
996
|
|
|
‡2
ISNI|0000000399638284
|
996
|
|
|
‡2
DNB|117598518
|
996
|
|
|
‡2
ISNI|0000000027923762
|
996
|
|
|
‡2
NTA|073300772
|
996
|
|
|
‡2
BIBSYS|90277256
|
996
|
|
|
‡2
DNB|1194873138
|
996
|
|
|
‡2
RERO|A018845641
|
996
|
|
|
‡2
ISNI|0000000431711403
|
996
|
|
|
‡2
ISNI|0000000059595433
|
996
|
|
|
‡2
RERO|A003624046
|
996
|
|
|
‡2
BNF|16401584
|
996
|
|
|
‡2
CAOONL|ncf13802490
|
996
|
|
|
‡2
DNB|1130188647
|
996
|
|
|
‡2
DNB|136272398
|
996
|
|
|
‡2
PLWABN|9810660000405606
|
996
|
|
|
‡2
ISNI|0000000389815996
|
996
|
|
|
‡2
SUDOC|262041510
|
996
|
|
|
‡2
NII|DA14720008
|
996
|
|
|
‡2
ISNI|0000000399255822
|
996
|
|
|
‡2
DNB|1157460097
|
996
|
|
|
‡2
BNF|17127873
|
996
|
|
|
‡2
DNB|1019745991
|
996
|
|
|
‡2
LC|no2020011903
|
996
|
|
|
‡2
ISNI|0000000020460507
|
996
|
|
|
‡2
DNB|137824866
|
996
|
|
|
‡2
DNB|1322945942
|
996
|
|
|
‡2
DNB|137824831
|
996
|
|
|
‡2
LC|no2010140249
|
996
|
|
|
‡2
DE633|pe30023588
|
996
|
|
|
‡2
RERO|A026876194
|
996
|
|
|
‡2
SUDOC|23164146X
|
996
|
|
|
‡2
ISNI|0000000385987002
|
996
|
|
|
‡2
BNF|17763663
|
996
|
|
|
‡2
ISNI|0000000400867077
|
996
|
|
|
‡2
SUDOC|203614879
|
996
|
|
|
‡2
SUDOC|138921962
|
996
|
|
|
‡2
RERO|A003624036
|
996
|
|
|
‡2
LC|no2022123234
|
996
|
|
|
‡2
NKC|jcu2016917796
|
996
|
|
|
‡2
LC|n 97019819
|
996
|
|
|
‡2
DNB|1021051543
|
996
|
|
|
‡2
DNB|1178349713
|
996
|
|
|
‡2
DNB|133091708
|
996
|
|
|
‡2
RERO|A018206835
|
996
|
|
|
‡2
BIBSYS|14046175
|
996
|
|
|
‡2
SZ|1091067120
|
996
|
|
|
‡2
DNB|1218808454
|
996
|
|
|
‡2
ISNI|0000000059059788
|
996
|
|
|
‡2
DNB|1196053472
|
996
|
|
|
‡2
NUKAT|n 2013143946
|
996
|
|
|
‡2
NTA|370671902
|
996
|
|
|
‡2
DNB|1037983769
|
996
|
|
|
‡2
DNB|128823216
|
996
|
|
|
‡2
NKC|ola2012699359
|
996
|
|
|
‡2
SUDOC|189268018
|
996
|
|
|
‡2
BIBSYS|14044813
|
996
|
|
|
‡2
SUDOC|050476742
|
996
|
|
|
‡2
LC|n 2001031255
|
996
|
|
|
‡2
DNB|1187689785
|
996
|
|
|
‡2
LIH|LNB:BJ_z__g_;=B9
|
996
|
|
|
‡2
SUDOC|200131362
|
996
|
|
|
‡2
LC|n 2019071358
|
996
|
|
|
‡2
RERO|A013203234
|
996
|
|
|
‡2
DNB|172727243
|
996
|
|
|
‡2
ISNI|000000043167880X
|
996
|
|
|
‡2
NUKAT|n 2013187450
|
996
|
|
|
‡2
DNB|1052492444
|
996
|
|
|
‡2
NII|DA05209704
|
996
|
|
|
‡2
BNF|15634631
|
996
|
|
|
‡2
SUDOC|19307625X
|
996
|
|
|
‡2
SUDOC|175331960
|
996
|
|
|
‡2
DNB|1234918412
|
996
|
|
|
‡2
BNF|16263235
|
996
|
|
|
‡2
DE633|pe30054069
|
996
|
|
|
‡2
NUKAT|n 2007007675
|
996
|
|
|
‡2
SUDOC|236398113
|
996
|
|
|
‡2
RERO|A012358613
|
996
|
|
|
‡2
SUDOC|197523617
|
996
|
|
|
‡2
ISNI|0000000002734607
|
996
|
|
|
‡2
SUDOC|068547463
|
996
|
|
|
‡2
ISNI|0000000108253596
|
996
|
|
|
‡2
ISNI|0000000112505071
|
996
|
|
|
‡2
SUDOC|132959453
|
996
|
|
|
‡2
LC|n 87819926
|
996
|
|
|
‡2
NTA|291106358
|
996
|
|
|
‡2
DNB|117577502
|
996
|
|
|
‡2
ISNI|0000000021312004
|
996
|
|
|
‡2
DNB|105351512X
|
996
|
|
|
‡2
DNB|119764032
|
996
|
|
|
‡2
DNB|1037652290
|
996
|
|
|
‡2
DNB|1052718086
|
996
|
|
|
‡2
DNB|104162244
|
996
|
|
|
‡2
DNB|1157700462
|
996
|
|
|
‡2
BAV|495_294711
|
996
|
|
|
‡2
NTA|147545307
|
996
|
|
|
‡2
SUDOC|073012572
|
996
|
|
|
‡2
DNB|119764040
|
996
|
|
|
‡2
DNB|1030235414
|
996
|
|
|
‡2
DNB|107349148X
|
996
|
|
|
‡2
DNB|128786337
|
997
|
|
|
‡a
0 0 lived 0 0
‡9
1
|
998
|
|
|
‡a
Muller, Laurent,
‡c
biologiste,
‡2
SUDOC|19307625X
‡3
suggested
|